Objectives
After participating in this educational activity, attendees should be able to:
1|Discuss various conceptual frameworks of combination therapy
2|Describe current evidence for advanced combination therapy in IBD
3|Outline the future of advanced combination therapy
4|Apply recommendations for current practice
Presenter(s):
Marla Dubinsky, MD
Professor of Pediatric and Medicine
Chief Division Pediatric GI and Nutrition
Co-Director Susan and Leonard Feinstein IBD Center
Director, Marie and Barry Lipman IBD Preconception and Pregnancy Planning Clinic
Icahn School of Medicine Mount Sinai, New York
Co-Founder & CEO, Trellus Health
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
Marla Dubinsky, MD | Speaker | Consultant: Abiva, Abbvie, Alimentiv, Amgen, AstraZeneca Relationships have been mitagated. | Real world studies on dual therapy will be discussed and trials |
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the other planners or faculty for this educational event have commercial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 APA American Psychological AssociationBaystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward